Early increase in marker of neuronal integrity with antidepressant treatment of major depression: 1H-magnetic resonance spectroscopy of N-acetyl-aspartate

International Journal of Neuropsychopharmacology

Volumn 15, Issue 10, 2012, Pages 1541-1546

  Taylor, Matthew J ^a,c   Godlewska, Beata R ^a   Norbury, Ray ^a,b   Selvaraj, Sudhakar ^a,c   Near, Jamie ^a   Cowen, Philip J ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antidepressant; depression; magnetic resonance spectroscopy; N acetyl aspartate

Indexed keywords

ESCITALOPRAM; N ACETYLASPARTIC ACID; PLACEBO;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; NERVE CELL CHARACTERISTICS AND FUNCTIONS; NEUROCHEMISTRY; NEURONAL INTEGRITY; PARALLEL DESIGN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SHORT COURSE THERAPY;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; ASPARTIC ACID; BIOLOGICAL MARKERS; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEURONS; PROTONS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867242369     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145712000272     Document Type: Article

References (26)

1. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961). An inventory for measuring depression. Archives of General Psychiatry 4, 561-571.
2. Bottomley PA (1987). Spatial localization in NMR spectroscopy in vivo. Annals of the New York Academy of Sciences 508, 333-348.
3. Duan D-M, Tu Y, Jiao S, Qin W (2011). The relevance between symptoms and magnetic resonance imaging analysis of the hippocampus of depressed patients given electro-acupuncture combined with fluoxetine intervention-a randomized, controlled trial. Chinese Journal of Integrative Medicine 17, 190-199.
4. First MB, Spitzer RL, Gibbon M, Williams JBW (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders. New York: Biometrics Research, New York State Psychiatric Institute.
5. Gonul AS, Kitis O, Ozan E, Akdeniz F, et al. (2006). The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients. Progress in Neuropsychopharmacology and Biological Psychiatry 30, 120-125.
6. Hamilton M (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 6, 278-296.
7. Harmer CJ, Shelley NC, Cowen PJ, Goodwin GM (2004). Increased positive vs. negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. American Journal of Psychiatry 161, 1256-1263.
8. Henigsberg N, Bajs M, Hrabac P, Kalember P, et al. (2011). Changes in brain metabolites measured with magnetic resonance spectroscopy in antidepressant responders with comorbid major depression and posttraumatic stress disorder. Collegium Antropologicum 35, 145-148.
9. Huang Y, Chen W, Li Y, Wu X, et al. (2010). Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients : a study using (1)H magnetic resonance spectroscopy. Psychiatry Research 182, 48-52.
10. Hurd R, Sailasuta N, Srinivasan R, Vigneron DB, et al. (2004). Measurement of brain glutamate using TEaveraged PRESS at 3T. Magnetic Resonance in Medicine 51, 435-440.
11. Jang JH, Kwon JS, Jang DP, Moon W, et al. (2006). A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder. American Journal of Psychiatry 163, 1202-1207.
12. Kaymak SU, Demir B, Ogiuz KK, Sentu rk S, Uluge B (2009). Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-nave female patients with first-episode major depression. Psychiatry and Clinical Neurosciences 63, 350-356.
13. Mathew SJ, Price RB, Shungu DC, Mao X, et al. (2010). A pilot study of the effects of chronic paroxetine administration on hippocampal N-acetylaspartate in generalized anxiety disorder. Journal of Psychopharmacology 24, 1175-1181.
14. Merkl A, Schubert F, Quante A, Luborzewski A, et al. (2010). Abnormal cingulate and prefrontal cortical neurochemistry in major depression after electroconvulsive therapy. Biological Psychiatry 69, 772-779.
15. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AMA (2007). N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Progress in Neurobiology 81, 89-131.
16. Portella MJ, de Diego-Adeliño J, Gomez-Anson B, Morgan-Ferrando R, et al. (2011). Ventromedial prefrontal spectroscopic abnormalities over the course of depression: a comparison among first episode, remitted recurrent and chronic patients. Journal of Psychiatry Research 45, 427-434.
17. Provencher SW (1993). Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance Medicine 30, 672-679.
18. Schmidt HD, Duman RS (2007). The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behavioural Pharmacology 18, 391-418.
19. Spielberger CD, Gorsuch RL, Lushene RE (1970). The State-Trait Anxiety Inventory : Test Manual. Palo Alto, CA: Consulting Psychologist Press.
20. Taylor M, Murphy SE, Selvaraj S, Wylezinska M, et al. (2008). Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy. Journal of Psychopharmacology 22, 473-476.
21. Taylor MJ, Freemantle N, Geddes JR, Bhagwagar Z (2006). Early onset of selective serotonin reuptake inhibitor antidepressant action : systematic review and meta-analysis. Archives of General Psychiatry 63, 1217-1223.
22. Taylor MJ, Norbury R, Murphy S, Rudebeck S, et al. (2010). Lack of effect of citalopram on magnetic resonance spectroscopy measures of glutamate and glutamine in frontal cortex of healthy volunteers. Journal of Psychopharmacology 24, 1217-1221.
23. van der Hart MGC, Czeh B, de Biurrun G, Michaelis T, et al. (2002). Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume. Molecular Psychiatry 7, 933-941.
24. Vanhamme L, van den Boogaart A, Van Huffel S (1997). Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. Journal of Magnetic Resonance 129, 35-43.
25. Yildiz-Yesiloglu A, Ankerst DP (2006). Review of 1H magnetic resonance spectroscopy findings in major depressive disorder : a meta-analysis. Psychiatry Research 147, 1-25.
26. Yuksel C, Ongur D (2010). Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biological Psychiatry 68, 785-794.